FORA Capital’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

FORA Capital’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,654	Closed	-$151K	–	1182
2020 Q4	$151K	Buy	+2,654	New	+$157K	0.02%	570
2020 Q3	–	Sell	-1,790	Closed	-$107K	–	1054
2020 Q2	$107K	Sell	1,790 -2,283	-56%	-$122K	0.04%	478
2020 Q1	$168K	Buy	+4,073	New	+$226K	0.04%	489

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FORA Capital's DCPH Position: Q1 2021 in Review

FORA Capital sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 2,654 shares — an estimated $151K sold.

FORA Capital first reported a position in DCPH in Q1 2020 and held it in 3 quarters. The position peaked at $168K in Q1 2020. 167 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

FORA Capital reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
FORA Capital sold 2,654 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $151K.
FORA Capital first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
FORA Capital's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $168K in Q1 2020.
167 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on FORA Capital's 13F filing for Q1 2021, filed 17 May 2021.